Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Bristol Myers Squibb Operating Income 2010-2025 | BMY

Bristol Myers Squibb annual/quarterly operating income history and growth rate from 2010 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Bristol Myers Squibb operating income for the quarter ending March 31, 2025 was $2.970B, a 125.79% decline year-over-year.
  • Bristol Myers Squibb operating income for the twelve months ending March 31, 2025 was $6.107B, a 204.46% decline year-over-year.
  • Bristol Myers Squibb annual operating income for 2024 was $-8.379B, a 199.28% decline from 2023.
  • Bristol Myers Squibb annual operating income for 2023 was $8.44B, a 9.43% increase from 2022.
  • Bristol Myers Squibb annual operating income for 2022 was $7.713B, a 4.75% decline from 2021.
  
Bristol Myers Squibb Annual Operating Income
(Millions of US $)
2024 $-8,379
2023 $8,440
2022 $7,713
2021 $8,098
2020 $-6,871
2019 $4,975
2018 $5,968
2017 $5,131
2016 $5,915
2015 $2,077
2014 $2,381
2013 $2,891
2012 $4,170
2011 $6,981
2010 $6,071
2009 $5,320
Bristol Myers Squibb Quarterly Operating Income
(Millions of US $)
2025-03-31 $2,970
2024-12-31 $175
2024-09-30 $1,676
2024-06-30 $1,286
2024-03-31 $-11,516
2023-12-31 $1,674
2023-09-30 $2,137
2023-06-30 $1,859
2023-03-31 $2,770
2022-12-31 $1,859
2022-09-30 $2,209
2022-06-30 $1,958
2022-03-31 $1,687
2021-12-31 $1,858
2021-09-30 $2,157
2021-06-30 $1,553
2021-03-31 $2,530
2020-12-31 $-10,451
2020-09-30 $2,257
2020-06-30 $1,627
2020-03-31 $-304
2019-12-31 $-129
2019-09-30 $1,349
2019-06-30 $1,776
2019-03-31 $1,979
2018-12-31 $1,505
2018-09-30 $2,167
2018-06-30 $517
2018-03-31 $1,779
2017-12-31 $698
2017-09-30 $1,183
2017-06-30 $1,295
2017-03-31 $1,955
2016-12-31 $1,086
2016-09-30 $1,559
2016-06-30 $1,615
2016-03-31 $1,655
2015-12-31 $-410
2015-09-30 $987
2015-06-30 $52
2015-03-31 $1,448
2014-12-31 $-60
2014-09-30 $1,008
2014-06-30 $448
2014-03-31 $985
2013-12-31 $869
2013-09-30 $818
2013-06-30 $530
2013-03-31 $674
2012-12-31 $513
2012-09-30 $571
2012-06-30 $1,059
2012-03-31 $2,027
2011-12-31 $1,717
2011-09-30 $1,767
2011-06-30 $1,768
2011-03-31 $1,729
2010-12-31 $1,593
2010-09-30 $1,581
2010-06-30 $1,531
2010-03-31 $1,366
2009-12-31 $1,252
2009-09-30 $1,477
2009-06-30 $1,419
2009-03-31 $1,172
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $96.341B $48.300B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $222.488B 16.61
Amgen (AMGN) United States $159.715B 14.31
Gilead Sciences (GILD) United States $139.432B 14.48
Vertex Pharmaceuticals (VRTX) United States $121.298B 0.00
GSK (GSK) United Kingdom $78.393B 9.38
CSL (CSLLY) Australia $77.367B 0.00
Regeneron Pharmaceuticals (REGN) United States $61.604B 14.95
Alnylam Pharmaceuticals (ALNY) United States $41.170B 0.00
Argenex SE (ARGX) Netherlands $34.350B 93.55
BioNTech SE (BNTX) Germany $26.684B 0.00
Royalty Pharma (RPRX) United States $20.376B 8.61
Biogen (BIIB) United States $19.504B 8.41
Insmed (INSM) United States $19.330B 0.00
Illumina (ILMN) United States $15.597B 29.59
Genmab (GNMSF) Denmark $14.203B 14.52
Genmab (GMAB) Denmark $13.768B 15.44
Incyte (INCY) United States $13.546B 102.91
Moderna (MRNA) United States $12.712B 0.00
Exelixis (EXEL) United States $12.430B 21.10
BioMarin Pharmaceutical (BMRN) United States $11.167B 18.14
QIAGEN (QGEN) Netherlands $10.732B 20.88
Ascendis Pharma (ASND) Denmark $10.691B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.413B 26.59
Exact Sciences (EXAS) United States $10.243B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.911B 0.00
Blueprint Medicines (BPMC) United States $8.354B 0.00
Bio-Techne Corp (TECH) United States $8.249B 30.77
Roivant Sciences (ROIV) United Kingdom $7.906B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $7.259B 0.00
Legend Biotech (LEGN) United States $7.248B 0.00
Revolution Medicines (RVMD) United States $7.147B 0.00
Halozyme Therapeutics (HALO) United States $7.104B 13.60
Bio-Rad Laboratories (BIO.B) United States $7.014B 24.41
Anbio Biotechnology (NNNN) Germany $6.858B 0.00
Repligen (RGEN) United States $6.817B 76.31
Jazz Pharmaceuticals (JAZZ) Ireland $6.743B 6.62
TG Therapeutics (TGTX) United States $6.179B 162.17
Guardant Health (GH) United States $6.166B 0.00
Nuvalent (NUVL) United States $6.074B 0.00
Rhythm Pharmaceuticals (RYTM) United States $5.672B 0.00
Axsome Therapeutics (AXSM) United States $5.531B 0.00
Telix Pharmaceuticals (TLX) Australia $5.269B 0.00
Alkermes (ALKS) Ireland $4.896B 13.14
CRISPR Therapeutics AG (CRSP) Switzerland $4.873B 0.00
Vaxcyte (PCVX) United States $4.693B 0.00
Cytokinetics (CYTK) United States $4.608B 0.00
Metsera (MTSR) United States $4.462B 0.00
ADMA Biologics Inc (ADMA) United States $4.460B 33.36
Krystal Biotech (KRYS) United States $4.347B 33.50
Akero Therapeutics (AKRO) United States $4.204B 0.00
Zealand Pharma (ZLDPF) Denmark $4.088B 0.00
Avidity Biosciences (RNA) United States $4.046B 0.00
PTC Therapeutics (PTCT) United States $3.920B 6.82
Arcellx (ACLX) United States $3.853B 0.00
Merus (MRUS) Netherlands $3.850B 0.00
Zai Lab (ZLAB) China $3.808B 0.00
Scholar Rock Holding (SRRK) United States $3.664B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.664B 32.19
Viking Therapeutics (VKTX) United States $3.552B 0.00
Protagonist Therapeutics (PTGX) United States $3.423B 73.64
MoonLake Immunotherapeutics (MLTX) Switzerland $3.256B 0.00
Immunovant (IMVT) United States $3.180B 0.00
Ascentage Pharma Group - (AAPG) China $3.154B 0.00
Kymera Therapeutics (KYMR) United States $2.924B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.831B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.763B 0.00
Alvotech (ALVO) Luxembourg $2.683B 15.35
Mirum Pharmaceuticals (MIRM) United States $2.639B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.570B 0.00
ImmunityBio (IBRX) United States $2.560B 0.00
Apellis Pharmaceuticals (APLS) United States $2.502B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.502B 0.00
Ligand Pharmaceuticals (LGND) United States $2.449B 0.00
Agios Pharmaceuticals (AGIO) United States $2.272B 0.00
Twist Bioscience (TWST) United States $2.265B 0.00
Bavarian Nordic (BVNRY) Denmark $2.193B 11.59
Recursion Pharmaceuticals (RXRX) United States $2.146B 0.00
Denali Therapeutics (DNLI) United States $2.134B 0.00
Beam Therapeutics (BEAM) United States $2.129B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.102B 0.00
Belite Bio (BLTE) United States $2.024B 0.00
Vericel (VCEL) United States $2.005B 1327.33
Disc Medicine (IRON) United States $2.000B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.993B 13.25
IDEAYA Biosciences (IDYA) United States $1.978B 0.00
CG Oncology (CGON) United States $1.974B 0.00
NovoCure (NVCR) Jersey $1.942B 0.00
Amicus Therapeutics (FOLD) United States $1.921B 208.00
Arcutis Biotherapeutics (ARQT) United States $1.895B 0.00
Sarepta Therapeutics (SRPT) United States $1.890B 0.00
Certara (CERT) United States $1.807B 33.76
Apogee Therapeutics (APGE) United States $1.790B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.773B 0.00
Adaptive Biotechnologies (ADPT) United States $1.755B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.745B 0.00
89BIO (ETNB) United States $1.623B 0.00
Celldex Therapeutics (CLDX) United States $1.551B 0.00
Janux Therapeutics (JANX) United States $1.549B 0.00
Vera Therapeutics (VERA) United States $1.517B 0.00
Travere Therapeutics (TVTX) United States $1.502B 0.00
Edgewise Therapeutics (EWTX) United States $1.465B 0.00
Biohaven (BHVN) United States $1.449B 0.00
GRAIL (GRAL) United States $1.445B 0.00
Mesoblast (MESO) Australia $1.427B 0.00
ANI Pharmaceuticals (ANIP) United States $1.412B 14.55
Viridian Therapeutics (VRDN) United States $1.398B 0.00
Dynavax Technologies (DVAX) United States $1.290B 76.71
AbCellera Biologics (ABCL) Canada $1.265B 0.00
Cogent Biosciences (COGT) United States $1.263B 0.00
Pharvaris (PHVS) Netherlands $1.245B 0.00
Liquidia Technologies (LQDA) United States $1.238B 0.00
Intellia Therapeutics (NTLA) United States $1.238B 0.00
CureVac (CVAC) Germany $1.225B 5.93
MannKind (MNKD) United States $1.225B 25.19
WAVE Life Sciences (WVE) Singapore $1.220B 0.00
Novavax (NVAX) United States $1.129B 2.63
Structure Therapeutics (GPCR) United States $1.122B 0.00
Cidara Therapeutics (CDTX) United States $1.115B 0.00
Praxis Precision Medicines (PRAX) United States $1.092B 0.00
Pacira BioSciences (PCRX) United States $1.079B 10.27
Arcus Biosciences (RCUS) United States $1.022B 0.00
MiMedx (MDXG) United States $1.004B 24.29
Spyre Therapeutics (SYRE) United States $0.989B 0.00
Anavex Life Sciences (AVXL) United States $0.980B 0.00
Mineralys Therapeutics (MLYS) United States $0.979B 0.00
Nurix Therapeutics (NRIX) United States $0.970B 0.00
Sana Biotechnology (SANA) United States $0.952B 0.00
LENZ Therapeutics (LENZ) United States $0.949B 0.00
Zymeworks (ZYME) United States $0.930B 0.00
Oric Pharmaceuticals (ORIC) United States $0.925B 0.00
NeoGenomics (NEO) United States $0.924B 0.00
Niagen Bioscience (NAGE) United States $0.887B 125.11
Jyong Biotech (MENS) Taiwan $0.883B 0.00
Sionna Therapeutics (SION) United States $0.880B 0.00
Replimune (REPL) United States $0.870B 0.00
GH Research (GHRS) Ireland $0.858B 0.00
Geron (GERN) United States $0.853B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.848B 0.00
Trevi Therapeutics (TRVI) United States $0.822B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.808B 0.00
UniQure (QURE) Netherlands $0.797B 0.00
Oculis Holding AG (OCS) Switzerland $0.793B 0.00
AnaptysBio (ANAB) United States $0.792B 0.00
BGM Group (BGM) China $0.786B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
CorMedix Inc (CRMD) United States $0.770B 51.64
Vir Biotechnology (VIR) United States $0.760B 0.00
ArriVent BioPharma (AVBP) United States $0.748B 0.00
Immatics (IMTX) Germany $0.743B 0.00
Immunome (IMNM) United States $0.740B 0.00
Nuvation Bio (NUVB) United States $0.728B 0.00
MeiraGTx Holdings (MGTX) United States $0.714B 0.00
Gyre Therapeutics (GYRE) United States $0.713B 190.25
Pharming Group (PHAR) Netherlands $0.709B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.705B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.702B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.700B 0.00
Maze Therapeutics (MAZE) United States $0.689B 0.00
Iovance Biotherapeutics (IOVA) United States $0.671B 0.00
Urogen Pharma (URGN) United States $0.668B 0.00
Tango Therapeutics (TNGX) United States $0.660B 0.00
Stoke Therapeutics (STOK) United States $0.658B 15.27
Prime Medicine (PRME) United States $0.646B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Dianthus Therapeutics (DNTH) United States $0.644B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.633B 0.00
Upstream Bio (UPB) United States $0.631B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.629B 0.00
Arbutus Biopharma (ABUS) United States $0.621B 0.00
Keros Therapeutics (KROS) United States $0.592B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.582B 0.00
Tyra Biosciences (TYRA) United States $0.579B 0.00
Precigen (PGEN) United States $0.576B 0.00
Arvinas (ARVN) United States $0.574B 0.00
Sage Therapeutics (SAGE) United States $0.573B 0.00
Castle Biosciences (CSTL) United States $0.563B 38.24
Abivax SA (ABVX) France $0.560B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.560B 0.00
Bicara Therapeutics (BCAX) United States $0.555B 0.00
Kura Oncology (KURA) United States $0.550B 0.00
Zenas BioPharma (ZBIO) United States $0.536B 0.00
Septerna (SEPN) United States $0.535B 0.00
Rapport Therapeutics (RAPP) United States $0.534B 0.00
Opthea (OPT) Australia $0.525B 0.00
Celcuity (CELC) United States $0.521B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.505B 0.00
ATyr Pharma (ATYR) United States $0.492B 0.00
Myriad Genetics (MYGN) United States $0.481B 0.00
Cullinan Therapeutics (CGEM) United States $0.464B 0.00
MBX Biosciences (MBX) United States $0.464B 0.00
Rezolute (RZLT) United States $0.455B 0.00
Fortrea Holdings (FTRE) United States $0.453B 12.52
Kamada (KMDA) Israel $0.447B 26.83
Terns Pharmaceuticals (TERN) United States $0.446B 0.00
REGENXBIO (RGNX) United States $0.436B 0.00
Tectonic Therapeutic (TECX) United States $0.432B 0.00
PureTech Health (PRTC) United States $0.428B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.427B 0.00
Fulcrum Therapeutics (FULC) United States $0.426B 0.00
Cytek Biosciences (CTKB) United States $0.424B 0.00
Solid Biosciences (SLDB) United States $0.424B 0.00
Erasca (ERAS) United States $0.414B 0.00
Compass Therapeutics (CMPX) United States $0.404B 0.00
Emergent Biosolutions (EBS) United States $0.396B 0.00
ITeos Therapeutics (ITOS) United States $0.396B 0.00
Eton Pharmaceuticals (ETON) United States $0.390B 0.00
Northwest Biotherapeutics (NWBO) United States $0.387B 0.00
Vigil Neuroscience (VIGL) United States $0.385B 0.00
Humacyte (HUMA) United States $0.383B 0.00
Astria Therapeutics (ATXS) United States $0.374B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.361B 0.00
Benitec Biopharma (BNTC) United States $0.348B 0.00
Gossamer Bio (GOSS) United States $0.348B 0.00
Prothena (PRTA) Ireland $0.346B 0.00
Absci (ABSI) United States $0.339B 0.00
Aura Biosciences (AURA) United States $0.339B 0.00
Cartesian Therapeutics (RNAC) United States $0.339B 0.00
Amarin (AMRN) Ireland $0.333B 0.00
Inhibrx Biosciences (INBX) United States $0.332B 0.20
ADC Therapeutics SA (ADCT) Switzerland $0.332B 0.00
XOMA Royalty (XOMA) United States $0.332B 0.00
Inventiva S.A (IVA) France $0.331B 0.00
Olema Pharmaceuticals (OLMA) United States $0.330B 0.00
Foghorn Therapeutics (FHTX) United States $0.328B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.326B 0.00
Ocugen (OCGN) United States $0.324B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.324B 65.75
Candel Therapeutics (CADL) United States $0.322B 0.00
Atea Pharmaceuticals (AVIR) United States $0.322B 0.00
Neurogene (NGNE) United States $0.317B 0.00
Palvella Therapeutics (PVLA) United States $0.305B 0.00
Abeona Therapeutics (ABEO) United States $0.303B 0.00
Lifecore Biomedical (LFCR) United States $0.303B 0.00
Vor Biopharma (VOR) $0.299B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.297B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.293B 0.00
Sagimet Biosciences (SGMT) United States $0.290B 0.00
Annexon (ANNX) United States $0.286B 0.00
Allogene Therapeutics (ALLO) United States $0.282B 0.00
DBV Technologies S.A (DBVT) France $0.280B 0.00
Tvardi Therapeutics (TVRD) United States $0.279B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.277B 0.00
Cardiff Oncology (CRDF) United States $0.275B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.273B 0.00
Kodiak Sciences (KOD) United States $0.273B 0.00
Verastem (VSTM) United States $0.273B 0.00
Monopar Therapeutics (MNPR) United States $0.267B 0.00
Aardvark Therapeutics (AARD) United States $0.263B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.261B 0.00
Entrada Therapeutics (TRDA) United States $0.258B 8.40
Codexis (CDXS) United States $0.254B 0.00
Crescent Biopharma (CBIO) United States $0.250B 0.00
Prima BioMed (IMMP) Australia $0.247B 0.00
Third Harmonic Bio (THRD) United States $0.246B 0.00
Adherex Technologies (FENC) United States $0.243B 0.00
Alpha Teknova (TKNO) United States $0.240B 0.00
Editas Medicine (EDIT) United States $0.239B 0.00
MaxCyte (MXCT) United States $0.238B 0.00
ScPharmaceuticals (SCPH) United States $0.237B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.234B 0.00
Semper Paratus Acquisition (TVGN) United States $0.232B 0.00
Design Therapeutics (DSGN) United States $0.227B 0.00
Adocia (ADOCY) France $0.216B 0.00
CARGO Therapeutics (CRGX) United States $0.212B 0.00
AC Immune (ACIU) Switzerland $0.209B 0.00
Neumora Therapeutics (NMRA) United States $0.205B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.201B 0.00
BioStem Technologies (BSEM) $0.201B 8.16
Ventyx Biosciences (VTYX) United States $0.200B 0.00
SELLAS Life Sciences (SLS) United States $0.198B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.197B 0.00
Alumis (ALMS) United States $0.196B 0.00
CytomX Therapeutics (CTMX) United States $0.193B 4.98
Kyverna Therapeutics (KYTX) United States $0.190B 0.00
Voyager Therapeutics (VYGR) United States $0.190B 0.00
GENFIT S.A (GNFT) France $0.190B 0.00
Agenus (AGEN) United States $0.187B 0.00
Bright Minds Biosciences (DRUG) United States $0.181B 0.00
I-Mab (IMAB) United States $0.175B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.173B 0.00
DiaMedica Therapeutics (DMAC) United States $0.172B 0.00
Nuvectis Pharma (NVCT) United States $0.172B 0.00
Puma Biotechnology (PBYI) United States $0.171B 4.48
EnGene Holdings (ENGN) Canada $0.171B 0.00
C4 Therapeutics (CCCC) United States $0.169B 0.00
Alpha Cognition (ACOG) Canada $0.169B 0.00
Black Diamond Therapeutics (BDTX) United States $0.167B 49.00
Alector (ALEC) United States $0.167B 0.00
BioAge Labs (BIOA) United States $0.166B 0.00
Anika Therapeutics (ANIK) United States $0.165B 0.00
MiNK Therapeutics (INKT) United States $0.162B 0.00
Instil Bio (TIL) United States $0.161B 0.00
Caribou Biosciences (CRBU) United States $0.158B 0.00
Innate Pharma S.A (IPHA) France $0.157B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.152B 0.00
Immuneering (IMRX) United States $0.150B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.149B 0.00
Spero Therapeutics (SPRO) United States $0.148B 0.00
Theratechnologies (THTX) Canada $0.145B 0.00
Greenwich LifeSciences (GLSI) United States $0.145B 0.00
Rapt Therapeutics (RAPT) United States $0.144B 0.00
Elicio Therapeutics (ELTX) United States $0.144B 0.00
Molecular Partners AG (MOLN) Switzerland $0.143B 0.00
Compugen (CGEN) Israel $0.142B 0.00
Citius Oncology (CTOR) United States $0.139B 0.00
23andMe Holding (MEHCQ) United States $0.136B 0.00
Nkarta (NKTX) United States $0.134B 0.00
Fate Therapeutics (FATE) United States $0.131B 0.00
Seres Therapeutics (MCRB) United States $0.130B 0.00
Genelux (GNLX) United States $0.128B 0.00
Seer (SEER) United States $0.125B 0.00
Skye Bioscience (SKYE) United States $0.122B 0.00
Actuate Therapeutics (ACTU) United States $0.122B 0.00
Cellectis S.A (CLLS) France $0.120B 0.00
Sangamo Therapeutics (SGMO) United States $0.117B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.116B 0.00
BioHarvest Sciences (BHST) Canada $0.116B 0.00
Tenaya Therapeutics (TNYA) United States $0.116B 0.00
Oncolytics Biotech (ONCY) Canada $0.113B 0.00
IO Biotech (IOBT) Denmark $0.112B 0.00
Coherus Oncology (CHRS) United States $0.110B 0.00
HilleVax (HLVX) United States $0.109B 0.00
TScan Therapeutics (TCRX) United States $0.109B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.103B 0.00
Coya Therapeutics (COYA) United States $0.103B 0.00
TuHURA Biosciences (HURA) United States $0.102B 0.00
Nautilus Biotechnology (NAUT) United States $0.099B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.098B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.098B 0.00
Whitehawk Therapeutics (WHWK) United States $0.097B 0.00
Contineum Therapeutics (CTNM) United States $0.097B 0.00
Climb Bio (CLYM) United States $0.096B 0.00
BeyondSpring (BYSI) United States $0.092B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.090B 0.00
Pliant Therapeutics (PLRX) United States $0.089B 0.00
Zura Bio (ZURA) United States $0.089B 0.00
XBiotech (XBIT) United States $0.088B 0.00
OKYO Pharma (OKYO) $0.087B 0.00
Invivyd (IVVD) United States $0.087B 0.00
Adagene (ADAG) China $0.086B 0.00
Cabaletta Bio (CABA) United States $0.086B 0.00
Elutia (ELUT) United States $0.084B 0.00
EXoZymes (EXOZ) United States $0.082B 0.00
Entera Bio (ENTX) Israel $0.082B 0.00
IGM Biosciences (IGMS) United States $0.081B 0.00
Quince Therapeutics (QNCX) United States $0.081B 0.00
Immix Biopharma (IMMX) United States $0.081B 0.00
Immunic (IMUX) United States $0.080B 0.00
TELA Bio (TELA) United States $0.079B 0.00
Connect Biopharma Holdings (CNTB) United States $0.078B 0.00
Oncobiologics (OTLK) United States $0.078B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.074B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.074B 0.00
Biomea Fusion (BMEA) United States $0.073B 0.00
Alto Neuroscience (ANRO) United States $0.073B 0.00
VistaGen Therapeutics (VTGN) United States $0.069B 0.00
Genenta Science S.p.A (GNTA) Italy $0.069B 0.00
Repare Therapeutics (RPTX) Canada $0.067B 0.00
Opus Genetics (IRD) United States $0.066B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.066B 0.00
Ikena Oncology (IKNA) United States $0.066B 0.00
Forte Biosciences (FBRX) United States $0.065B 0.00
Sutro Biopharma (STRO) United States $0.065B 0.00
Clearside Biomedical (CLSD) United States $0.064B 0.00
Adicet Bio (ACET) United States $0.064B 0.00
MediciNova (MNOV) United States $0.063B 0.00
CervoMed (CRVO) United States $0.062B 0.00
Earth Science Tech (ETST) United States $0.062B 0.00
Quantum Biopharma (QNTM) Canada $0.061B 0.00
InflaRx (IFRX) Germany $0.060B 0.00
ABVC BioPharma (ABVC) United States $0.060B 0.00
Applied Therapeutics (APLT) United States $0.060B 0.00
Cue Biopharma (CUE) United States $0.059B 0.00
Fortress Biotech (FBIO) United States $0.058B 0.00
Werewolf Therapeutics (HOWL) United States $0.058B 0.00
Adverum Biotechnologies (ADVM) United States $0.057B 0.00
PDS Biotechnology (PDSB) United States $0.056B 0.00
Annovis Bio (ANVS) United States $0.056B 0.00
Adlai Nortye (ANL) Cayman Islands $0.056B 0.00
Atara Biotherapeutics (ATRA) United States $0.055B 0.00
Celularity (CELU) United States $0.054B 0.00
VTv Therapeutics (VTVT) United States $0.053B 0.00
Aligos Therapeutics (ALGS) United States $0.053B 0.00
Artiva Biotherapeutics (ARTV) United States $0.053B 0.00
Jasper Therapeutics (JSPR) United States $0.052B 0.00
ZIVO Bioscience (ZIVO) United States $0.052B 0.00
Precision BioSciences (DTIL) United States $0.051B 0.00
Senti Biosciences (SNTI) United States $0.051B 0.00
RenovoRx (RNXT) United States $0.051B 0.00
INmune Bio (INMB) United States $0.050B 0.00
Inovio Pharmaceuticals (INO) United States $0.050B 0.00
Kalaris Therapeutics (KLRS) United States $0.049B 0.00
Renovaro (RENB) United States $0.048B 0.00
Grace Therapeutics (GRCE) Canada $0.046B 0.00
Exicure (XCUR) United States $0.044B 0.00
Rani Therapeutics Holdings (RANI) United States $0.044B 0.00
Scilex Holding (SCLX) United States $0.044B 0.00
Lantern Pharma (LTRN) United States $0.043B 0.00
Mersana Therapeutics (MRSN) United States $0.043B 0.00
Medicus Pharma (MDCX) United States $0.042B 0.00
PepGen (PEPG) United States $0.042B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.041B 0.00
Alterity Therapeutics - (ATHE) Australia $0.041B 0.00
Pluri (PLUR) Israel $0.040B 0.00
Shattuck Labs (STTK) United States $0.039B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.039B 0.00
Xilio Therapeutics (XLO) United States $0.038B 0.00
Cognition Therapeutics (CGTX) United States $0.038B 0.00
KALA BIO (KALA) United States $0.037B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.036B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.035B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.035B 0.00
OnKure Therapeutics (OKUR) United States $0.034B 0.00
Kezar Life Sciences (KZR) United States $0.033B 0.00
Rein Therapeutics (RNTX) United States $0.033B 0.00
Radiopharm Theranostics - (RADX) Australia $0.033B 0.00
CalciMedica (CALC) United States $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
Estrella Immunopharma (ESLA) United States $0.032B 0.00
Clene (CLNN) United States $0.031B 0.00
Femasys (FEMY) United States $0.031B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.031B 0.00
CAMP4 Therapeutics (CAMP) United States $0.030B 0.00
Generation Bio (GBIO) United States $0.030B 0.00
Dyadic (DYAI) United States $0.029B 0.00
Ovid Therapeutics (OVID) United States $0.028B 0.00
Dare Bioscience (DARE) United States $0.027B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.027B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.026B 0.00
Boundless Bio (BOLD) United States $0.026B 0.00
FibroBiologics (FBLG) United States $0.025B 0.00
ALX Oncology Holdings (ALXO) United States $0.025B 0.00
SAB Biotherapeutics (SABS) United States $0.025B 0.00
Q32 Bio (QTTB) United States $0.025B 0.00
Cadrenal Therapeutics (CVKD) United States $0.025B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
BioAtla (BCAB) United States $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
Elevation Oncology (ELEV) United States $0.023B 0.00
Chemomab Therapeutics (CMMB) Israel $0.022B 0.00
Longeveron (LGVN) United States $0.021B 0.00
Passage Bio (PASG) United States $0.021B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.021B 0.00
Cingulate (CING) United States $0.020B 0.00
Curis (CRIS) United States $0.020B 0.00
Aytu BioPharma (AYTU) United States $0.019B 0.00
Hoth Therapeutics (HOTH) United States $0.019B 0.00
Rallybio (RLYB) United States $0.017B 0.00
Advanced Biomed (ADVB) United States $0.017B 0.00
Promis Neurosciences (PMN) Canada $0.017B 0.00
Gelteq (GELS) Australia $0.017B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.016B 0.00
Allarity Therapeutics (ALLR) United States $0.016B 0.00
Athira Pharma (ATHA) United States $0.016B 0.00
Edesa Biotech (EDSA) Canada $0.015B 0.00
Lexaria Bioscience (LEXX) Canada $0.015B 0.00
HOOKIPA Pharma (HOOK) United States $0.015B 0.00
Synlogic (SYBX) United States $0.015B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.014B 0.00
Synaptogenix (TAOX) United States $0.014B 0.00
MetaVia (MTVA) United States $0.014B 0.00
BRIACELL THERAP (BCTX) Canada $0.014B 0.00
Leap Therapeutics (LPTX) United States $0.014B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.013B 0.00
Beyond Air (XAIR) United States $0.013B 0.00
NextCure (NXTC) United States $0.013B 0.00
Equillium (EQ) United States $0.013B 0.00
BioCardia (BCDA) United States $0.013B 0.00
IBio (IBIO) United States $0.013B 0.00
BioXcel Therapeutics (BTAI) United States $0.012B 0.00
Abpro Holdings (ABP) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.012B 0.00
Novogen (KZIA) Australia $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.011B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
GeoVax Labs (GOVX) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Cyclerion Therapeutics (CYCN) United States $0.011B 0.00
Mustang Bio (MBIO) United States $0.011B 0.00
LakeShore Biopharma (LSB) China $0.010B 0.00
Sensei Biotherapeutics (SNSE) United States $0.010B 0.00
Artelo Biosciences (ARTL) United States $0.010B 0.00
GENPREX (GNPX) United States $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
Imunon (IMNN) United States $0.009B 0.00
Moleculin Biotech (MBRX) United States $0.009B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.009B 0.00
X4 Pharmaceuticals (XFOR) United States $0.009B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.008B 0.00
Jade Biosciences (JBIO) United States $0.008B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Purple Biotech (PPBT) Israel $0.007B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Mainz Biomed (MYNZ) Germany $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
Apollomics (APLM) United States $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
180 Life Sciences (ATNF) United States $0.005B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
GRI Bio (GRI) United States $0.005B 0.00
Tharimmune (THAR) United States $0.005B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.004B 0.00
Adial Pharmaceuticals (ADIL) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00